Association of chemokines and their receptors genes polymorphisms with risk of myocardial infarction

Chinese Journal of Medical Genetics

Volumn 30, Issue 5, 2013, Pages 601-607

  Xu, Xin ^a   Wang, Li Han ^a   Liu, Hai Bo ^b   Xu, Chang Fu ^c   Zhang, Peng ^d   Yong, Fen Di ^e   Shi, Yu Ping ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Yinzhou People's Hospital   (China)

^c ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^d SHAOXING PEOPLE S HOSPITAL   (China)

^e Jiaxing First Hospital   (China)

Author keywords

Chemokine receptors gene; Chemokines genes; Genetic polymorphism; Myocardial infarction

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CHEMOKINE CCL5; CHINA; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CCR2; RECEPTORS, CCR5; RISK FACTORS;

EID: 84888365734     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1003-9406.2013.05.021     Document Type: Article

References (22)

1. Charo IF, Taubman MB. Chemokines in the pathogenesis of vascular disease. Circ Res, 2004, 95: 858-866.
2. An P, Nelson GW, Wang L, et al. Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc Natl Acad Sci U S A, 2002, 99: 10002-10007.
3. Simeoni E, Winkelmann BR, Hoffmann MM, et al. Association of RANTES G - 403A gene polymorphism with increased risk of coronary arteriosclerosis. Eur Heart J, 2004, 25: 1438-1446.
4. Wang FS, Liu DP. Polymorphism of human alleles associated with genetic resistance against HIV-1 infection and its implications. Chin J Med Genet, 2000, 17: 285-287.
5. Rovin BH, Lu L, Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun, 1999, 259: 344-348.
6. Gonzalez P, Alvarez R, Batalla A, et al. Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction. Genes Immun, 2001, 2: 191-195.
7. Zhang X, Han Y, Kang J, et al. A monocyte chemoattractant protein-1 gene polymorphism is not associated with coronary artery disease in a Han Chinese population. Clin Chim Acta, 2009, 403: 241-243.
8. Hajeer AH, Al Sharif F, Ollier WE. A polymorphism at position - 403 in the human RANTES promoter. Eur J Immunogenet, 1999, 26: 375-376.
9. Kallel A, Abdessalem S, Sediri Y, et al. Polymorphisms in the CC-chemokine receptor-2(CCR2) and -5(CCR5) genes and risk of myocardial infarction among Tunisian male patients. Clin Biochem, 2012, 45: 420-424.
10. Iwane M, Palensky J, Plante K. A user's review of commercial sample size software for design of biomedical studies using survival data. Control Clin Trials, 1997, 18: 65-83.
11. Tregouet DA, Garelle V. A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies. Bioinformatics, 2007, 23: 1038-1039.
12. Boger CA, Fischereder M, Deinzer M, et al. RANTES gene polymorphisms predict all-cause and cardiac mortality in type 2 diabetes mellitus hemodialysis patients. Atherosclerosis, 2005, 183: 121-129.
13. Nickel RG, Casolaro V, Wahn U, et al. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol, 2000, 164: 1612-1616.
14. Vogiatzi K, Voudris V, Apostolakis S, et al. Genetic diversity of RANTES gene promoter and susceptibility to coronary artery disease and restenosis after percutaneous coronary intervention. Thromb Res, 2009, 124: 84-89.
15. Kim WJ, Chereshnev I, Gazdoiu M, et al. MCP-1 deficiency is associated with reduced intimai hyperplasia after arterial injury. Biochem Biophys Res Commun, 2003, 310: 936-942.
16. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature, 1998, 394: 894-897.
17. Bjarnadottir K, Eiriksdottir G, Aspelund T, et al. Examination of genetic effects of polymorphisms in the MCP-1 and CCR2 genes on MI in the Icelandic population. Atherosclerosis, 2006, 188: 341-346.
18. Martinson JJ, Chapman NH, Rees DC, et al. Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet, 1997, 16: 100-103.
19. Wang FS, Hong WG, Cao Y, et al. Population survey of CCR5 delta32, CCR5 m303, CCR2b 64I, and SDFI 3′ A allele frequencies in indigenous Chinese healthy individuals, and in HIV-1-infected and HIV-1-uninfected individuals in HIV-1 risk groups. J Acquir Immune Defic Syndr, 2003, 32: 124-130.
20. Cam SF, Sekuri C, Sagcan A, et al. Effect of monocyte chemoattractant protein-1 (MCP-1) gene polymorphism in Turkish patients with premature coronary artery disease. Scand J Clin Lab Invest, 2008, 68: 801-805.
21. Petrkova J, Cermakova Z, Drabek J, et al. CC chemokine receptor (CCR) 2 polymorphism in Czech patients with myocardial infarction. Immunol Lett, 2003, 88: 53-55.
22. Hong WG, Wang FS, Jin L, et al. Genotyping of HIV resistant alleles in indigenous Tibetan ethnic group of China: low frequency of CCR5 Δ32 and high frequency of CCR2b -64I alleles. Chin J Med Genet, 2001, 18: 268-271.